24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
31/01/2015
Iranian entrepreneurs at the ALBA synchrotron
22/01/2015
What is a synchrotron and how it works?
15/01/2015
AFM2015 at ICMAB: Nanoscale Characterization of Functional Materials
08/01/2015
Ice under investigation: ICN2 and ICMAB sign an agreement with SnowWorld
23/12/2014
Kymos Pharma Services in the PTV
18/12/2014
Barcelona is one of the 20 best cities for students